Literature DB >> 29985526

Opioid Therapy in Acute and Chronic Pain.

Anne N Nafziger1,2, Robert L Barkin3,4.   

Abstract

This is an article in the Core Entrustables in Clinical Pharmacology series that describes opioid therapy in acute and chronic pain. Opioid use during surgical procedures or anesthesia is not discussed. Basic pharmacokinetic and pharmacodynamic properties of opioids are reviewed. The safe and effective use of opioids, including clinical assessment and treatment plan, equianalgesic dosing, opioid rotation, opioid risks and side effects, and clinical adherence monitoring are discussed. Individualized opioid use can be a safe and effective component of a patient-specific multimodal treatment plan for acute or chronic pain. Adverse effects and risks can be prevented or effectively managed when anticipated and recognized. The article is followed by 4 clinical vignettes with discussions.
© 2018, The American College of Clinical Pharmacology.

Entities:  

Keywords:  Analgesics; Drug therapy; Opioid; Opioid-related disorders; Pain management; Treatment outcome

Mesh:

Substances:

Year:  2018        PMID: 29985526     DOI: 10.1002/jcph.1276

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  16 in total

1.  The efficacy of acupressure in managing opioid-induced constipation in patients with cancer: A single-blind randomized controlled trial.

Authors:  Dilek Yildirim; Vildan Kocatepe; Gül Köknel Talu
Journal:  Support Care Cancer       Date:  2022-03-07       Impact factor: 3.603

Review 2.  Opioid Use Consequences, Governmental Strategies, and Alternative Pain Control Techniques Following Total Hip Arthroplasties.

Authors:  Kevin Berardino; Austin H Carroll; Daniel Popovsky; Robert Ricotti; Matthew D Civilette; William F Sherman; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

3.  The clinician's guide to prevention and treatment of osteoporosis.

Authors:  M S LeBoff; S L Greenspan; K L Insogna; E M Lewiecki; K G Saag; A J Singer; E S Siris
Journal:  Osteoporos Int       Date:  2022-04-28       Impact factor: 5.071

4.  Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic.

Authors:  John Ngo; David Parker; Mathew Meroney; Jasmine Mitchell; Oscar Veloz; Oliver Lee; Katherine A Cunningham; Denise Wilkes
Journal:  J Pain Res       Date:  2020-08-25       Impact factor: 3.133

5.  Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old.

Authors:  Feras Khalil; Siak Leng Choi; Estelle Watson; Thomas M Tzschentke; Claudia Lefeber; Mariëlle Eerdekens; Jan Freijer
Journal:  J Pain Res       Date:  2020-11-24       Impact factor: 3.133

6.  Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress.

Authors:  Mengyuan Tan; Hanyu Wang; Cheng Gao; Zhen Jiang; Ying Yin; Ruyi Xing; Ling Hu; Jiegou Xu; Min Zhang; Yanhu Xie
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

7.  Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain.

Authors:  Yuqiang Shi; Subo Yuan; Shao-Jun Tang
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-22       Impact factor: 7.285

8.  The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine.

Authors:  Anne N Nafziger; Kelly A Arscott; Kristina Cochrane; Franck Skobieranda; David A Burt; Michael J Fossler
Journal:  Clin Pharmacol Drug Dev       Date:  2019-11-07

Review 9.  Tapentadol: an overview of the safety profile.

Authors:  Enrico Polati; Pier Luigi Canonico; Vittorio Schweiger; Massimo Collino
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

10.  An Audio-Recorded Hypnosis Intervention for Chronic Pain Management in Cancer Survivors: A Randomized Controlled Pilot Study.

Authors:  Linda H Eaton; Susan L Beck; Mark P Jensen
Journal:  Int J Clin Exp Hypn       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.